Randomized Trial of Cannabis Extract in Parki...

Dr. Shuvro Roy and Dr. Michael Levy discuss satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. Read more about this abstract. 

In part three of this series, Dr. Aaron Zelikovich discusses the clinical outcomes seen during and after the acute infection and how these findings can guide physicians in counseling their patients. Show citation: Solomon T, Hooper C, Easton A, et al. Safety and efficacy of adjun ...  Show more

Parkinson’s is caused by a deficiency in dopamine, so what if you ate foods rich in the dopamine precursor levodopa? This episode features audio from Treating Parkinson’s Disease with Velvet Beans (Mucuna pruriens) and Treating Parkinson’s Disease with Fava Beans (Faba or Broad B ...  Show more

In this episode I cover Parkinson's disease.

If you want to follow along with written notes on Parkinson's disease go to https://zerotofinals.com/medicine/neurology/parkinsons/ or the neur ...

Guest: Jeremy K. Cutsforth-Gregory, M.D. (@JCGneuro)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Parkinson’s Disease is one of the more common neurodegenerative diseases, in fact, ...

The medications used to treat Parkinson’s disease can be complicated and hard to remember. In this episode, our newest team member MS3 Rachel Garza reviews the pharmacologic options for Parkinson’s treatment, including their mechanisms and side effects. We always try to explain c ...  Show more